Last reviewed · How we verify

NCT03059199

HAT TRICK: An Innovative Health Promotion Program for Men

Completed NA Last updated 1 November 2018
What this trial tests

NA trial testing Single-Arm Feasibility Study in Cancer Prevention in 61 participants. Completed in 22 June 2018.

Timeline
20 October 2016
Primary endpoint
22 June 2018
22 June 2018

Quick facts

Lead sponsorUniversity of British Columbia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment61
Start date20 October 2016
Primary completion22 June 2018
Estimated completion22 June 2018
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of British Columbia

Who can join

35 and older, male only, with Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to implement and evaluate the feasibility of the HAT- TRICK Program, a gender- sensitive intervention program targeting physical activity, healthy eating and connectedness in men living in the Okanagan Region, BC.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Men's Perspectives of a Gender-Sensitized Health Promotion Program Targeting Healthy Eating, Active Living, and Social Connectedness.
    Sharp P, Bottorff JL, Hunt K, Oliffe JL, et al · · 2018 · cited 32× · PMID 30234419 · DOI 10.1177/1557988318799159

Verify or expand the search:

Other trials of Single-Arm Feasibility Study

Trials testing the same drug.

Other recruiting trials for Cancer Prevention

Currently open trials in the same condition.

Other University of British Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03059199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing